The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.
If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. If you’ve ever wondered why some people seem to keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results